Navigation Links
Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
Date:7/6/2012

HOLLYWOOD, Calif., July 6, 2012 /PRNewswire/ -- Medbox, Inc. (Pinksheets: MDBX) (www.medboxinc.com) recently offered some comments about the ongoing debate over how to implement self-service medication dispensing systems within pharmacies, and how to best maintain quality control, safety and security.

The FDA held a two-day hearing in March, where it heard from a variety of stakeholders on the public health implications of self-service prescription medicine dispensing. The purpose of the hearing was to evaluate the best ways to implement a prescription drug kiosk program "under conditions of safe use intended to ensure appropriate use by consumers, and (examine) the potential benefits and costs of this type of approach," according to Yolanda A. Fultz-Morris of the Center for Drug Evaluation and Research for the U.S. Food and Drug Administration.

"Medication-dispensing kiosks could be the next step in the hybrid of health care and self-service," according to a recent article on SelfServiceWorld.com. Patients already use kiosks to test their blood pressure, check-in for a doctor's appointment, and learn about health problems. Now, prescription medicine dispensing systems "are the next step in user-friendly health care," the article stated.

However, in contrast to many kiosk manufacturers that are trying to enter this emerging industry, Medbox differs greatly in their approach. The Medbox Rx system does not allow patients to self-diagnose, nor does it take the pharmacist out of the process, which are two of the biggest hurdles now facing the FDA's implementation of similar technology.

The Medbox Rx is a unique system that allows pharmacists to load a customer's medicine into a secure lockbox for later retrieval. The customer can pick up their medicine at their convenience through the self-service system by swiping their authorization card and placing their index finger on a scanner. Once the patient's identity has been verified, a lockbox door opens and they can access their medicine. 

The Medbox Rx system also maintains a permanent record of each operation, including a photograph of every person conducting a transaction, thereby increasing security while virtually eliminating fraud.

Because the system is designed to lighten the pharmacist's workload while increasing their capacity and enhancing the customer experience, it functions as a type of "Pharmacist's Assistant."

Other kiosk manufacturers are proposing that patients should be allowed to self-diagnose certain conditions and have the kiosk provide the medication, without ever consulting a doctor or pharmacist.

Medbox strongly opposes this idea, and believes that the best use of kiosk technology is to assist pharmacists while enhancing the customer experience by reducing wait times and increasing convenience.

About Medbox, Inc:  Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo, Connecticut, Arizona and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to www.medboxinc.com.


'/>"/>
SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medbox, Inc. Rides a Wave of Local Media Support in Connecticut
2. Phreesia identifies over 26% of patients who require additional autism evaluation
3. Partnership Aims to Prevent Students from Misusing Prescription Drugs
4. American Society of Hematology Statement on House Passage of Prescription Drug User Fee Act (PDUFA)
5. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
6. American Society of Hematology Statement on Senate Passage of Prescription Drug User Fee Act (PDUFA)
7. Parent Project Muscular Dystrophy Endorses Senate Version of Prescription Drug User Fee Act After Patient Voice Strengthened
8. Kmart® Launches New Pet Prescription Program And Purina® Treat Giveaway
9. Blue Cross Blue Shield of Michigan and Blue Care Network support the Drug Enforcement Administrations Nationwide Prescription "Drug Take-Back Day"
10. Polish Medicine Attracts Patients From Abroad - Not Only During EURO 2012
11. China Botanics Siberian Ginseng Extract Recognized as Safe Medicine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... -- OrthoAccel ® Technologies, Inc. announces that the ... Effect of Vibration on Molar Distalization," a study that ... Jay Bowman , this prospective, peer-reviewed clinical study concluded ... ® speeds up molar distalization rates in the ... days to move the upper molars into a normal, ...
(Date:1/17/2017)... 2017   Tocagen Inc ., a clinical-stage, cancer-selective gene therapy ... president, research and pharmaceutical development at Tocagen, will present at ... Jan. 17-20 in Miami . ... ... for replicating viruses - what to do when and why Date ...
(Date:1/17/2017)... Jan. 17, 2017  EMD Serono, the biopharmaceutical business ... in the U.S. and Canada , ... joined the company as Senior Vice President and Head ... Smith will oversee the Fertility and Endocrinology businesses in ... launched its first product last year with Gidget™, a ...
Breaking Medicine Technology:
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic Research will demonstrate its ... Merchants (NAMM) winter trade show, Booth #2876, at the Anaheim Convention Center in ... the gold standard for high-definition, in-ear earphones. This classic earphone has been updated ...
(Date:1/17/2017)... ... January 17, 2017 , ... Mirror Mirror Beauty Boutique, Houston’s premiere CoolSculpting ... Level in Zeltiq’s Crystal Rewards Program. Practice founder, Paul Vitenas, MD FACS, is delighted ... providers. , Produced by Zeltiq, CoolSculpting is approved by the Food and Drug ...
(Date:1/17/2017)... ... January 17, 2017 , ... Surgeons from New York’s ... care practitioners on the latest breakthroughs in the prevention, diagnosis and treatment of ... according to eye surgeon, Jeffrey Martin, MD, FACS, Chief Executive Officer of SightMD ...
(Date:1/17/2017)... ... ... Neil H. Greco Insurance Agency, a northern New Jersey firm that provides ... a charity drive to raise awareness of heart disease and promote habits that improve ... is responsible for 1 in every 4 deaths at the national level each year. ...
(Date:1/17/2017)... ... January 17, 2017 , ... Livionex, Inc., a Silicon Valley healthcare ... blind clinical study for its dental gel that shows significant reduction in plaque levels ... containing triclosan. The study was conducted at the Beckman Laser Institute at UC Irvine ...
Breaking Medicine News(10 mins):